These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851 [TBL] [Abstract][Full Text] [Related]
4. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658 [TBL] [Abstract][Full Text] [Related]
5. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells. Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8 Eissa IR; Mukoyama N; Abdelmoneim M; Naoe Y; Matsumura S; Bustos-Villalobos I; Ichinose T; Miyajima N; Morimoto D; Tanaka M; Fujimoto Y; Sone M; Kodera Y; Kasuya H Int J Cancer; 2021 Jul; 149(1):214-227. PubMed ID: 33687756 [TBL] [Abstract][Full Text] [Related]
7. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses. Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839 [TBL] [Abstract][Full Text] [Related]
8. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice. Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220 [TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse. Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721 [TBL] [Abstract][Full Text] [Related]
10. DGKζ exerts greater control than DGKα over CD8 Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062 [TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol kinase ζ limits the polarized recruitment of diacylglycerol-enriched organelles to the immune synapse in T cells. Andrada E; Almena M; de Guinoa JS; Merino-Cortes SV; Liébana R; Arcos R; Carrasco S; Carrasco YR; Merida I Sci Signal; 2016 Dec; 9(459):ra127. PubMed ID: 27999176 [TBL] [Abstract][Full Text] [Related]
12. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. Shin J; Xie D; Zhong XP PLoS One; 2013; 8(10):e77983. PubMed ID: 24147106 [TBL] [Abstract][Full Text] [Related]
14. Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8 Harabuchi S; Khan O; Bassiri H; Yoshida T; Okada Y; Takizawa M; Ikeda O; Katada A; Kambayashi T Front Immunol; 2022; 13():1032113. PubMed ID: 36846018 [TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol Kinase ζ (DGKζ) Is a Critical Regulator of Bone Homeostasis Via Modulation of c-Fos Levels in Osteoclasts. Zamani A; Decker C; Cremasco V; Hughes L; Novack DV; Faccio R J Bone Miner Res; 2015 Oct; 30(10):1852-63. PubMed ID: 25891971 [TBL] [Abstract][Full Text] [Related]
16. SNX27 links DGKζ to the control of transcriptional and metabolic programs in T lymphocytes. Tello-Lafoz M; Rodríguez-Rodríguez C; Kinna G; Loo LS; Hong W; Collins BM; Teasdale RD; Mérida I Sci Rep; 2017 Nov; 7(1):16361. PubMed ID: 29180720 [TBL] [Abstract][Full Text] [Related]
18. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ. Moran AE; Polesso F; Weinberg AD J Immunol; 2016 Sep; 197(6):2509-21. PubMed ID: 27503208 [TBL] [Abstract][Full Text] [Related]
20. Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer. Wang C; Lu Y; Chen L; Gao T; Yang Q; Zhu C; Chen Y Int Immunopharmacol; 2020 Jan; 78():106019. PubMed ID: 31776089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]